Literature DB >> 32341933

Evidence of Failure of Oral Third-Generation Cephalosporin Treatment for Shigella sonnei Infection.

Jennifer P Collins1,2, Cindy R Friedman2, Meseret G Birhane2, Beth E Karp2, Anthony Osinski3, Mary W Montgomery4, Deepam Thomas5, Jonathan Barkley6, Martha C Sanchez7, Samir Hanna8, Azizat A Adediran9, Jessica C Chen9, Hayat Caidi9, Louise Francois Watkins2.   

Abstract

In 2017, state health departments notified the Centers for Disease Control and Prevention about 4 patients with shigellosis who experienced persistent illness after treatment with oral third-generation cephalosporins. Given increasing antibiotic resistance among Shigella, these cases highlight the need to evaluate the efficacy of oral cephalosporins for shigellosis. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2020.

Entities:  

Keywords:  Shigella sonnei; antibiotic resistance; antibiotic treatment failure; cephalosporin; shigellosis

Year:  2020        PMID： 32341933      PMCID： PMC7175969          DOI： 10.1093/ofid/ofaa113

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  9 in total

1.  Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children.

Authors:  Wilma Basualdo; Antonio Arbo
Journal:  Pediatr Infect Dis J       Date:  2003-04       Impact factor: 2.129

2.  Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil.

Authors:  Vasu Kumar Kakumanu; Vinod Arora; Arvind K Bansal
Journal:  Int J Pharm       Date:  2006-03-12       Impact factor: 5.875

3.  Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children.

Authors:  M Helvaci; D Bektaşlar; B Ozkaya; I Yaprak; B Umurtak; A Ertuğrul
Journal:  Acta Paediatr Jpn       Date:  1998-04

4.  Treatment of shigellosis with cefixime: two days vs. five days.

Authors:  J M Martin; R Pitetti; F Maffei; J Tritt; K Smail; E R Wald
Journal:  Pediatr Infect Dis J       Date:  2000-06       Impact factor: 2.129

Review 5.  Shigellosis.

Authors:  Karen L Kotloff; Mark S Riddle; James A Platts-Mills; Patricia Pavlinac; Anita K M Zaidi
Journal:  Lancet       Date:  2017-12-16       Impact factor: 79.321

6.  A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis.

Authors:  S Ashkenazi; J Amir; Y Waisman; A Rachmel; B Z Garty; Z Samra; I Varsano; M Nitzan
Journal:  J Pediatr       Date:  1993-11       Impact factor: 4.406

7.  Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults.

Authors:  M A Salam; C Seas; W A Khan; M L Bennish
Journal:  Ann Intern Med       Date:  1995-10-01       Impact factor: 25.391

8.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

9.  Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence.

Authors:  Phoebe C M Williams; James A Berkley
Journal:  Paediatr Int Child Health       Date:  2018-11       Impact factor: 1.990
  9 in total
  3 in total

1.  Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.

Authors:  Radhika Gharpure; Cindy R Friedman; Veronica Fialkowski; Jennifer P Collins; Jonathan Strysko; Zachary A Marsh; Jessica C Chen; Elizabeth H Meservey; Azizat A Adediran; Morgan N Schroeder; Ashutosh Wadhwa; Kathleen E Fullerton; Louise Francois Watkins
Journal:  Clin Infect Dis       Date:  2022-02-11       Impact factor: 9.079

2.  Shigella sonnei, an emerging multidrug-resistant sexually transmitted pathogen in Franche-Comté, France.

Authors:  Souheil Zayet; Timothée Klopfenstein; Alix Pierron; Pierre-Yves Royer; Lynda Toko; Pauline Garnier; Vincent Gendrin
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

3.  Evaluation of a Live Attenuated S. sonnei Vaccine Strain in the Human Enteroid Model.

Authors:  Giulia Pilla; Tao Wu; Christen Grassel; Jonathan Moon; Jennifer Foulke-Abel; Christoph M Tang; Eileen M Barry
Journal:  Pathogens       Date:  2021-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.